GPT and fibrosis: This guideline sets a stricter cut-off point for indications for treatment with all patients with HBeAg-positive or –negative chronic hepatitis B, a viral load of > 2.0 • 103 in combination with ALT greater than the upper limit of normal and/or at least moderate liver necroinflammation or fibrosis should be treated.